Accelerating progress through rigorous research
Like health itself, the infection landscape is highly dynamic. Multi-drug resistant organisms are becoming more intelligent, and hospital acquired infections (HAIs) continue to proliferate in global institutions despite thorough disinfection protocol. A challenge this formidable requires more than just promises; it demands an unwavering commitment to verifiable results. Decon-X International invests heavily in objective peer review and groundbreaking R&D, delivering solutions proven to eliminate 99.9999% of bacteria, spores and viruses. That’s what this challenge demands—and what every facility and patient deserves.
Solutions Proven by science
Decon-X is committed to helping healthcare institutions take control of their infection prevention today and as the healthcare landscape evolves. To deliver on that promise, we rigorously test every solution for both effective disinfection and a streamlined user experience. Leading research bodies have consistently confirmed the power of our technology in the world’s most demanding environments.
Research Council of Norway
Decon-X participated in a four-year research initiative sponsored by the Council, receiving innovation funds and the access to Norway’s best research environments to work on the next-generation automated disinfection technology. This research confirmed our technology’s ability to consistently eliminate 99.9999% of all bacteria, spores and viruses.
International Journal of Food Microbiology
In a 30 month scientific study, headed by Nofima, Decon-X was tested on the effect on listeria within food production areas. The results were published in 2019 in the International Journal of Food Microbiology. This study confirmed that the Decon-X system with H₂O₂ was effective against L. monocytogenes in suspension on open surfaces at conditions relevant to food production.
Norwegian Medicines Agency
The Agency concluded that Decon-X is effective against both gram-positive and gram-negative spores, viruses and fungi.